Literature DB >> 2842184

Molecular cloning and sequence analysis of cDNA encoding human prostatic acid phosphatase.

P Vihko1, P Virkkunen, P Henttu, K Roiko, T Solin, M L Huhtala.   

Abstract

lambda gt11 clones encoding human prostatic acid phosphatase (PAP) (EC 3.1.3.2) were isolated from human prostatic cDNA libraries by immunoscreening with polyclonal antisera. Sequence data obtained from several overlapping clones indicated that the composite cDNAs contained the complete coding region for PAP, which encodes a 354-residue protein with a calculated molecular mass of 41,126 Da. In the 5'-end, the cDNA codes for a signal peptide of 32 amino acids. Direct protein sequencing of the amino-terminus of the mature protein and its proteolytic fragments confirmed the identity of the predicted protein sequence. PAP has no apparent sequence homology to other known proteins. However, both the cDNA clones coding for human placental alkaline phosphatase and PAP have an alu-type repetitive sequence about 900 nucleotides downstream from the coding region in the 3'-untranslated region. Two of our cDNA clones differed from others at the 5'-ends. RNA blot analysis indicated mRNA of 3.3 kb. We are continuing to study whether acid phosphatases form a gene family as do alkaline phosphatases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842184     DOI: 10.1016/0014-5793(88)80037-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Nucleotide sequence of human prostatic acid phosphatase determined from a full-length cDNA clone.

Authors:  P G Tailor; M V Govindan; P C Patel
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

2.  The evaluation of markers of prostatic function.

Authors:  H von der Kammer; K H Scheit; W Weidner; T G Cooper
Journal:  Urol Res       Date:  1991

3.  Evolution of a bifunctional enzyme: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Authors:  J F Bazan; R J Fletterick; S J Pilkis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Vaccines as monotherapy and in combination therapy for prostate cancer.

Authors:  Julia Rotow; Sofia R Gameiro; Ravi A Madan; James L Gulley; Jeffrey Schlom; James W Hodge
Journal:  Clin Transl Sci       Date:  2010-06       Impact factor: 4.689

5.  Rat acid phosphatase: overexpression of active, secreted enzyme by recombinant baculovirus-infected insect cells, molecular properties, and crystallization.

Authors:  P Vihko; R Kurkela; K Porvari; A Herrala; A Lindfors; Y Lindqvist; G Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

6.  Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer.

Authors:  Ravi A Madan; James L Gulley
Journal:  Immunotherapy       Date:  2011-01       Impact factor: 4.196

7.  Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.

Authors:  P Castelo-Branco; B J Passer; J S Buhrman; S Antoszczyk; M Marinelli; C Zaupa; S D Rabkin; R L Martuza
Journal:  Gene Ther       Date:  2010-03-11       Impact factor: 5.250

8.  Novel human and mouse genes encoding an acid phosphatase family member and its downregulation in W/W(V) mouse jejunum.

Authors:  I Takayama; Y Daigo; S M Ward; K M Sanders; R L Walker; B Horowitz; T Yamanaka; M A Fujino
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

9.  Transcriptional activation of the human prostatic acid phosphatase gene by NF-kappaB via a novel hexanucleotide-binding site.

Authors:  Stanislav Zelivianski; Richard Glowacki; Ming-Fong Lin
Journal:  Nucleic Acids Res       Date:  2004-07-07       Impact factor: 16.971

Review 10.  Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.

Authors:  Sakthivel Muniyan; Matthew A Ingersoll; Surinder K Batra; Ming-Fong Lin
Journal:  Biochim Biophys Acta       Date:  2014-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.